Government SI Register · VA · High impact

Computer Aided Detection (CADe) of Neoplasia during Colonoscopy - “GI Genius”

The Department of Veterans Affairs lists "Computer Aided Detection (CADe) of Neoplasia during Colonoscopy - “GI Genius”" in the 2025 federal inventory as a high impact SI use case at the deployed stage, in VHA: Veterans Health Administration. In the agency's words, the problem it is meant to solve: "The device improves endoscopy quality by aiding neoplastic lesion detection during procedures. Multiple studies and meta-analyses have found these devices increase adenoma detection rates (ADR), a well-established metric for colonoscopy quality that is related to colon cancer incidence and death. Randomized implementation of the devices across VHA facilities allowed for a pragmatic evaluation of the impact of these ..." Every field below is quoted as filed.

ID VA-24-1684Stage DeployedSource row 3449

The record, as filed

Every field the agency reported

Bureau or component
VHA: Veterans Health Administration
Stage
Deployed
High impact status
High-impact
Topic area
Health and Medical
Technology type
Computer Vision
Problem it is meant to solve
The device improves endoscopy quality by aiding neoplastic lesion detection during procedures. Multiple studies and meta-analyses have found these devices increase adenoma detection rates (ADR), a well-established metric for colonoscopy quality that is related to colon cancer incidence and death. Randomized implementation of the devices across VHA facilities allowed for a pragmatic evaluation of the impact of these devices on ADR. The evaluation demonstrated that the provision of colonoscopy Computer Aided Detection devices resulted in a statistically significant 21% increase in the odds of adenoma detection and an absolute increase in ADR of approximately 4% compared to colonoscopy without CADe.
Expected benefits
These devices demonstrably improve endoscopy quality within the VHA, which in turn improves outcomes for Veterans, ultimately reducing morbidity and mortality. Multiple studies and meta-analyses have found these devices increase adenoma detection rates (ADR), a well-established metric for colonoscopy quality that is related to colon cancer incidence and death. Randomized implementation of the devices across VHA facilities allowed for a pragmatic evaluation of the impact of these devices on ADR. The evaluation demonstrated that the provision of colonoscopy Computer Aided Detection devices resulted in a statistically significant 21% increase in the odds of adenoma detection and an absolute increase in ADR of approximately 4% compared to colonoscopy without CADe.
What the system outputs
During endoscopy, the CADe device automatically detects, and highlights suspected neoplastic lesions / polyps in real time. A highlighted rectangle automatically surrounds suspected lesions. No results or data are tracked or automatically documented. The device physically connects to existing endoscopes, video processors, and display monitors, but does not connect to the VA network.
How it was built or bought
Vendor Purchased
Custom-developed code
No
Public source code
https://www.medtronic.com/covidien/en-us/products/gastrointestinal-artificial-intelligence

Left blank in the record: Justification given, Operational or pilot start, Vendors, Authorization to Operate, System name, Data used to train, tune or evaluate, Federal Data Catalog link, Uses personally identifiable information, Privacy Impact Assessment, Demographic features used, Pre-deployment testing, Impact assessment completed, Potential impacts identified, Independent review, Ongoing monitoring, Operator training, Fail-safe, Appeal process, Consultation with users and the public. Point of contact details are in the source file.

Source

Source: row 3449 of 2025_individually_reported_AI_use_cases.csv in OMB's 2025 Federal Agency AI Use Case Inventory repository (summary as of April 13, 2026), read Nov 17, 2026. File SHA-256 a62721202ca4b110

Life areas: Health and medicine, Veterans.

Records, not ratings. Every entry is what an agency reported to OMB, quoted as filed. The register does not test, rate or vouch for any system, and a record does not prove how a system is used day to day.